WO2008035325A1 - Procédé et appareil de traitement d'une onychomycose par rayonnement haute fréquence et/ou hyperfréquence - Google Patents
Procédé et appareil de traitement d'une onychomycose par rayonnement haute fréquence et/ou hyperfréquence Download PDFInfo
- Publication number
- WO2008035325A1 WO2008035325A1 PCT/IL2006/001102 IL2006001102W WO2008035325A1 WO 2008035325 A1 WO2008035325 A1 WO 2008035325A1 IL 2006001102 W IL2006001102 W IL 2006001102W WO 2008035325 A1 WO2008035325 A1 WO 2008035325A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nail
- energy
- tissue
- electromagnetic
- operative
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 96
- 206010034016 Paronychia Diseases 0.000 title claims description 12
- 230000005855 radiation Effects 0.000 title description 29
- 208000015181 infectious disease Diseases 0.000 claims abstract description 16
- 102000011782 Keratins Human genes 0.000 claims abstract description 7
- 108010076876 Keratins Proteins 0.000 claims abstract description 7
- 210000000282 nail Anatomy 0.000 claims description 345
- 210000004904 fingernail bed Anatomy 0.000 claims description 67
- 238000011282 treatment Methods 0.000 claims description 31
- 244000052769 pathogen Species 0.000 claims description 30
- 241000233866 Fungi Species 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 18
- 230000021715 photosynthesis, light harvesting Effects 0.000 claims description 18
- 230000008878 coupling Effects 0.000 claims description 14
- 238000010168 coupling process Methods 0.000 claims description 14
- 238000005859 coupling reaction Methods 0.000 claims description 14
- 230000002147 killing effect Effects 0.000 claims description 14
- 230000001717 pathogenic effect Effects 0.000 claims description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004202 carbamide Substances 0.000 claims description 11
- 239000011159 matrix material Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 230000002458 infectious effect Effects 0.000 claims description 10
- 244000053095 fungal pathogen Species 0.000 claims description 9
- 239000004020 conductor Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- 206010061304 Nail infection Diseases 0.000 claims description 6
- 239000013043 chemical agent Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 230000010363 phase shift Effects 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 5
- 230000004054 inflammatory process Effects 0.000 claims description 5
- 238000002203 pretreatment Methods 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 208000026721 nail disease Diseases 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000009832 plasma treatment Methods 0.000 claims description 3
- 238000002835 absorbance Methods 0.000 claims description 2
- 239000000615 nonconductor Substances 0.000 claims description 2
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims 3
- 206010017533 Fungal infection Diseases 0.000 abstract description 16
- 208000031888 Mycoses Diseases 0.000 abstract description 16
- 210000001519 tissue Anatomy 0.000 description 127
- 208000010195 Onychomycosis Diseases 0.000 description 27
- 201000005882 tinea unguium Diseases 0.000 description 21
- 210000002615 epidermis Anatomy 0.000 description 13
- 210000004906 toe nail Anatomy 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 12
- 230000001603 reducing effect Effects 0.000 description 11
- 210000004905 finger nail Anatomy 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 210000004207 dermis Anatomy 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 7
- 229920001971 elastomer Polymers 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 230000005670 electromagnetic radiation Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 5
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 4
- 241001480043 Arthrodermataceae Species 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 239000003990 capacitor Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000037304 dermatophytes Effects 0.000 description 4
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229960004130 itraconazole Drugs 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 229960002722 terbinafine Drugs 0.000 description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- 206010013710 Drug interaction Diseases 0.000 description 3
- 208000006187 Onycholysis Diseases 0.000 description 3
- 241000029132 Paronychia Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229960004884 fluconazole Drugs 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 150000003852 triazoles Chemical class 0.000 description 3
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 238000010336 energy treatment Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- MQHLMHIZUIDKOO-OKZBNKHCSA-N (2R,6S)-2,6-dimethyl-4-[(2S)-2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine Chemical compound C1=CC(C(C)(C)CC)=CC=C1C[C@H](C)CN1C[C@@H](C)O[C@@H](C)C1 MQHLMHIZUIDKOO-OKZBNKHCSA-N 0.000 description 1
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 1
- MBRHNTMUYWQHMR-UHFFFAOYSA-N 2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one Chemical compound NCCO.ON1C(=O)C=C(C)C=C1C1CCCCC1 MBRHNTMUYWQHMR-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 208000008818 Chronic Mucocutaneous Candidiasis Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 206010016948 Food interaction Diseases 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 229920000914 Metallic fiber Polymers 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 206010028080 Mucocutaneous candidiasis Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 206010062696 Spider vein Diseases 0.000 description 1
- 208000020312 Thickened skin Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241001459572 Trichophyton interdigitale Species 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960003204 amorolfine Drugs 0.000 description 1
- -1 and enconazole) Chemical compound 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002206 bifonazole Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229960004375 ciclopirox olamine Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940063123 diflucan Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 230000001329 hyperkeratotic effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- VHVPQPYKVGDNFY-ZPGVKDDISA-N itraconazole Chemical compound O=C1N(C(C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-ZPGVKDDISA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940089474 lamisil Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006298 saran Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XNRNJIIJLOFJEK-UHFFFAOYSA-N sodium;1-oxidopyridine-2-thione Chemical compound [Na+].[O-]N1C=CC=CC1=S XNRNJIIJLOFJEK-UHFFFAOYSA-N 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Electromagnetism (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
L'invention concerne des procédés et dispositifs de traitement de tissus biologiques durs, notamment de tissus durs riches en kératine, par de l'énergie électromagnétique dont la fréquence est comprise entre au moins 0,5 MHz (mégahertz) et 10 GHz (gigahertz) (par exemple de l'énergie HF, RF ou hyperfréquence). L'invention concerne plus particulièrement des procédés et dispositifs de traitement d'infections, notamment d'une onychomycose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2006/001102 WO2008035325A1 (fr) | 2006-09-20 | 2006-09-20 | Procédé et appareil de traitement d'une onychomycose par rayonnement haute fréquence et/ou hyperfréquence |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2006/001102 WO2008035325A1 (fr) | 2006-09-20 | 2006-09-20 | Procédé et appareil de traitement d'une onychomycose par rayonnement haute fréquence et/ou hyperfréquence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2008035325A1 true WO2008035325A1 (fr) | 2008-03-27 |
Family
ID=39200224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IL2006/001102 WO2008035325A1 (fr) | 2006-09-20 | 2006-09-20 | Procédé et appareil de traitement d'une onychomycose par rayonnement haute fréquence et/ou hyperfréquence |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008035325A1 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2187848A4 (fr) * | 2007-08-15 | 2011-04-20 | Zeno Corp | Traitement de champignon du lit de l'ongle par application de chaleur |
| EP2168523B1 (fr) * | 2008-09-30 | 2017-02-22 | Covidien LP | Système de fourniture intermittente d'énergie à micro-ondes |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6193713B1 (en) * | 1997-12-23 | 2001-02-27 | Sulzer Osypka Gmbh | Method for the operation of a high frequency ablation apparatus and apparatus for the high frequency tissue ablation |
-
2006
- 2006-09-20 WO PCT/IL2006/001102 patent/WO2008035325A1/fr not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6193713B1 (en) * | 1997-12-23 | 2001-02-27 | Sulzer Osypka Gmbh | Method for the operation of a high frequency ablation apparatus and apparatus for the high frequency tissue ablation |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2187848A4 (fr) * | 2007-08-15 | 2011-04-20 | Zeno Corp | Traitement de champignon du lit de l'ongle par application de chaleur |
| EP2168523B1 (fr) * | 2008-09-30 | 2017-02-22 | Covidien LP | Système de fourniture intermittente d'énergie à micro-ondes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090281537A1 (en) | Method and apparatus for treating a fungal nail infection with shortwave and/or microwave radiation | |
| US20230031914A1 (en) | Device including rf source of energy and vacuum system | |
| US20220273962A1 (en) | High power time varying magnetic field therapy | |
| US10493293B2 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| AU2017217934B2 (en) | Hyaline cartilage shaping | |
| EP2767308B1 (fr) | Dispositifs et systèmes d'administration non invasive d'une thérapie par micro-ondes | |
| US7744592B2 (en) | Apparatus and method for the treatment of infectious disease in keratinized tissue | |
| KR101577156B1 (ko) | 피하 치료를 위한 시스템 | |
| US20190201705A1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| Brightman et al. | Improvement in arm and post‐partum abdominal and flank subcutaneous fat deposits and skin laxity using a bipolar radiofrequency, infrared, vacuum and mechanical massage device | |
| US20180317998A1 (en) | Radio frequency treatment of sweat glands | |
| US20070106349A1 (en) | System and method for heating biological tissue via rf energy | |
| JP5781122B2 (ja) | マイクロ波療法の非侵襲的送達のための方法、装置およびシステム | |
| Malerich et al. | Radiofrequency: an update on latest innovations | |
| JP2007516012A (ja) | 角質化組織中の伝染病を治療する方法および装置 | |
| WO2008035325A1 (fr) | Procédé et appareil de traitement d'une onychomycose par rayonnement haute fréquence et/ou hyperfréquence | |
| Sankaran et al. | A Comprehensive Study on Design of Frequency Probe for Treatment of Plantar Corns and Warts using Microwave Technology | |
| Khandizod et al. | REVIEW ON THERAPEUTIC APPROACH OF AGNIKARMA | |
| Namazi | Electrocautery and Electrosurgery Pearls | |
| Chapas | Subcutaneous Body Skin Tightening | |
| Kumar et al. | AGNIKARMA THERAPY IN CLASSICAL AND PRESENT ERA–A CONCEPTUAL REVIEW | |
| KR20190070169A (ko) | 사마귀 고주파 치료용 니들팁 및 사마귀 고주파 치료장치 | |
| Choudhary et al. | Electrosurgery | |
| Goel | 8 Radio Frequency in Cosmetic Gynecology | |
| Gold | Lumenis Aluma Skin Tightening System |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06796109 Country of ref document: EP Kind code of ref document: A1 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2006348536 Country of ref document: AU |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |